Global NGS Automation Market

NGS Automation Market Size, Share, Growth Analysis, By product type(Workstation/Robotic Platform, Reagents & Consumables), By application(Drug Discovery, Clinical Diagnostics, Other Applications), By sequencing type(Whole Genome, Exome, Targeted), By End use(Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2270 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 117 | Figures: 68

NGS Automation Market Dynamics

NGS Automation Market Drivers

Increased Investment to Develop Healthcare Infrastructure to Boost Market Growth

  • The increased demand for automation in NGS workflow, the prevalence of cancer, rising R&D spending, and rising healthcare costs are just a few of the reasons contributing to the expansion of this industry. Additionally, this market is anticipated to experience significant expansion due to the expanding uses of next-generation sequencing and the growing number of corporate partnerships to create library preparation techniques.
  • NGS is a potent DNA sequencing method that can examine a genome in its entirety and find new viral variations. In the upcoming years, epidemiological research to differentiate between COVID-19, influenza, and other viruses is anticipated to heavily rely on NGS. These elements are anticipated to fuel the industry's expansion and increase its demand.

NGS Automation Market Restraints

High Cost with Installing Automation Workstations to Hinder Market Growth

  • This market's growth is anticipated to be significantly constrained by the high cost of automation workstations. The main obstacles to the expansion of this industry include issues with regulation and uniformity in diagnostic testing, as well as the need for highly skilled employees to operate automation software.
  • Any type of DNA sequencing, including NGS, is subject to legal and ethical considerations. In addition to concerns unique to a particular culture and group, these issues also include identifiability, releasing study findings, stereotyping, the appropriateness of consent, stigmatisation, inclusion, and differential benefit. In essence, these moral concerns restrain market expansion.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

NGS Automation Market was valued at USD 2214.93 billion in 2022, and is poised to grow from USD 2543.85 billion in 2023, to USD 7700.86 Billion by 2031 at a CAGR of 14.85% during the forecast period (2024-2031).

The competitive landscape for the next-generation sequencing (NGS) market includes information by competitor. An overview of the business, financials, revenue generated, market potential, investments in R&D, new market initiatives, production facilities, company strengths and weaknesses, product launches, product approval pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve are among the details provided. The data metrics mentioned above only pertain to the company's market focus on next-generation sequencing (NGS). 'Agilent Technologies', 'Bio-Rad Laboratories Inc.', 'DNASTAR Inc.', 'Eurofins Scientific', 'Hoffmann-La Roche Ltd', 'Illumina Inc.', 'Danaher Corporation (IDT)', 'Pacific Biosciences of California Inc.', 'PerkinElmer Inc.', 'Qiagen', 'Thermo Fisher Scientific Inc.'

The increased demand for automation in NGS workflow, the prevalence of cancer, rising R&D spending, and rising healthcare costs are just a few of the reasons contributing to the expansion of this industry. Additionally, this market is anticipated to experience significant expansion due to the expanding uses of next-generation sequencing and the growing number of corporate partnerships to create library preparation techniques.

Automation of NGS library preparation enables dependable and repeatable data creation by assisting researchers in library quality improvement and consistent yields. It also improves productivity and lowers costs. Reducing manual contact with the reagents and samples significantly lowers the risk of contamination. As a result, the market for NGS automation is anticipated to be driven by the rising demand for automation in NGS workflow.

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). The NGS automation market is expected to be dominated by North America, followed by Europe and Asia-Pacific. The significant market share held by North America is due in large part to the region's high R&D expenditures, growing demand for NGS automation in the pharmaceutical and biotech sectors, and expanding government support and investment in the region's genome sequencing infrastructure.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global NGS Automation Market

Report ID: SQMIG35A2270

$5,300
BUY NOW GET FREE SAMPLE